...
首页> 外文期刊>American Journal of Physiology >TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels.
【24h】

TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels.

机译:TAN-67是一种δ1阿片类受体激动剂,可通过激活Gi / o蛋白和KATP通道来减少梗塞面积。

获取原文
获取原文并翻译 | 示例

摘要

We have previously shown that delta (delta)-opioid receptors, most notably delta 1, are involved in the cardioprotective effect of ischemic preconditioning (PC) in rats; however, the mechanism by which delta-opioid receptor-induced cardioprotection is mediated remains unknown. Therefore, we hypothesized that several of the known mediators of ischemic PC such as the ATP-sensitive potassium (KATP) channel and Gi/o proteins are involved in the cardioprotective effect produced by delta 1-opioid receptor activation. To address these possibilities, anesthetized, open-chest Wistar rats were randomly assigned to five groups. Control animals were subjected to 30 min of coronary artery occlusion and 2 h of reperfusion. To demonstrate that stimulating delta 1-opioid receptors produces cardioprotection, TAN-67, a new selective delta 1-agonist, was infused for 15 min before the long occlusion and reperfusion periods. In addition, one group received 7-benzylidenenaltrexone (BNTX), a selective delta 1-antagonist, before TAN-67. To study the involvement of KATP channels or Gi/o proteins in delta 1-opioid receptor-induced cardioprotection, glibenclamide (Glib), a KATP channel antagonist, or pertussis toxin (PTX), an inhibitor of Gi/o proteins, was administered before TAN-67. Infarct size (IS) as a percentage of the area at risk (IS/AAR) was determined by tetrazolium stain. TAN-67 significantly reduced IS/AAR as compared with control (56 +/- 2 to 27 +/- 5%, n = 5, P < 0.05). The cardioprotective effect of TAN-67 was completely abolished by BNTX, Glib, and PTX (51 +/- 3, 53 +/- 5, and 61 +/- 4%, n = 6 for each group, respectively). These results are the first to suggest that stimulating the delta 1-opioid receptor elicits a cardioprotective effect that is mediated via Gi/o proteins and KATP channels in the intact rat heart.
机译:先前我们已经表明,δ(阿片)阿片受体,最著名的是δ1,参与了大鼠缺血预处理(PC)的心脏保护作用。然而,δ-阿片受体诱导的心脏保护介导的机制仍然未知。因此,我们假设缺血性PC的几种已知介体,例如ATP敏感钾(KATP)通道和Gi / o蛋白参与了由δ1阿片类受体激活产生的心脏保护作用。为了解决这些可能性,将麻醉的开胸Wistar大鼠随机分为五个组。对照动物经受30分钟的冠状动脉闭塞和2小时的再灌注。为了证明刺激性的δ1阿片样物质受体能产生心脏保护作用,在长期的闭塞和再灌注阶段之前,将新的选择性δ1激动剂TAN-67注入15分钟。此外,一组在TAN-67之前接受了7-亚苄基纳曲酮(BNTX),一种选择性的δ1拮抗剂。为了研究KATP通道或Gi / o蛋白在δ1阿片样物质受体诱导的心脏保护中的作用,在施用之前,先给予了GATP(KATP通道拮抗剂)或百日咳毒素(PTX)(一种Gi / o蛋白的抑制剂) TAN-67。通过四唑鎓染色确定梗塞面积(IS)占危险区域(IS / AAR)的百分比。与对照相比,TAN-67显着降低了IS / AAR(56 +/- 2至27 +/- 5%,n = 5,P <0.05)。 BNTX,Glib和PTX完全取消了TAN-67的心脏保护作用(每组分别为51 +/- 3、53 +/- 5和61 +/- 4%,n = 6)。这些结果首次表明刺激δ1-阿片样物质受体可引起心脏保护作用,该作用是通过完整大鼠心脏中的Gi / o蛋白和KATP通道介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号